Why Your Body Does Not Feel Like Yours Anymore

Named in October 2024 in the journal Climacteric, the musculoskeletal syndrome of menopause encompasses arthralgia, loss of muscle mass, loss of bone density, increased tendon and ligament injury, adhesive capsulitis, and cartilage matrix fragility. An estimated 70% of all midlife women experience this syndrome, 25% are disabled by it, and critically, 40% have no structural findings on imaging. This means standard diagnostic tools miss the condition in nearly half of affected women, leading to underdiagnosis and undertreatment.

I want to sit with that 40% figure because it represents an enormous population of women being told their scans look fine when their bodies feel broken. The musculoskeletal syndrome of menopause is primarily a soft tissue and neurochemical problem, not a structural one. Estrogen receptors exist in cartilage, synovium, tendon sheath, and periosteum. When estrogen declines, collagen turnover slows, synovial fluid viscosity drops, and central pain sensitization amplifies signals from tissues that appear normal on MRI.

Dr. Susan Davis at Monash University in Melbourne has argued that musculoskeletal symptoms should be reclassified as a primary menopausal symptom rather than an age-related comorbidity. Her reasoning: the onset clusters around the menopausal transition, the severity correlates with hormonal decline, and HRT can reduce symptoms. A 2024 retrospective study found that women on menopausal hormone therapy reported 38% less joint pain than untreated controls.

The naming matters. Before October 2024, women with this cluster of symptoms had no diagnostic label to unify their experience. Each symptom was treated separately: the shoulder went to orthopedics, the hip went to rheumatology, the fatigue went to primary care. Nobody connected them. Having a name gives women language for what their body is doing, and it gives clinicians a framework to treat the syndrome instead of chasing individual symptoms.

I want to share a finding that reframed how I think about this entire topic. Research by Sejourne and colleagues (2019) found that body image dissatisfaction is highest during perimenopause, not postmenopause. The unpredictability of the transition, with its rapid and non-linear changes, generates more distress than the settled state after menopause. The SWAN study (Jackson et al., 2014) found that midlife women who perceived themselves as unattractive had 7.74 times higher odds of clinical depression, establishing body image as a predictor of psychiatric morbidity rather than a cosmetic concern.

That trajectory is important and counterintuitive. Most women expect body dissatisfaction to get progressively worse with age. It does not. It peaks during the transition and then, for many women, eases. The explanation may be partly psychological: once the changes stabilize, the grief work can begin. During perimenopause, the body is a moving target. You cannot grieve what you have lost when you are still losing it. The unpredictability itself is the cruelest part.

A 2022 study in Body Image journal tracked 486 women across three menopausal stages and found that appearance-related rumination, not objective appearance change, was the strongest predictor of distress. Women who spent more time mentally evaluating their appearance had significantly higher depression and anxiety scores, regardless of their actual physical changes. Dr. Marika Tiggemann at Flinders University, who has studied body image for three decades, describes this as the 'monitoring trap': the more you watch for changes, the worse you feel, which drives more monitoring. I've seen this loop in my own mirror.

For women experiencing perimenopause body changes, this research offers an uncomfortable but useful insight. Some of the distress is driven not by the changes themselves but by the hypervigilance around them. That is not a reason to ignore real symptoms. It is a reason to distinguish between changes that need medical attention and changes that need psychological processing. Both are valid. But they require different interventions.